INCYTE CORPORATION Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss
INCYTE CORPORATION (INCY) reported Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss of $1.83 million for the 9-month period ending 2015-09-30, per its 10-Q filed 2015-11-03.
Discontinued › Income Statement › Other Income
us-gaap:MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments · last filed 2015-11-03
- 2015-09-30: Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss 9 month $1.83M.
| Period end | Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss 9 month |
|---|---|
| 2015-09-30 | $1.83M 10-Q · filed 2015-11-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| IQVIA HOLDINGS INC. (IQV) | United States | $45.926B | 20.54 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |